Cameron Durrant Insider Trading
Get free email notifications about insider trading for Cameron Durrant.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cameron Durrant. Cameron Durrant is a Director in IMMUNE PHARMACEUTICALS INC ($IMNP) and a Chairman and CEO in KALOBIOS PHARMACEUTICALS INC ($KBIO) and an Chief Executive Officer in KALOBIOS PHARMACEUTICALS INC ($KBIO) and a Director in ANAVEX LIFE SCIENCES CORP. ($AVXL).
Address: 90, FAIRMOUNT ROAD WEST CALIFON 07830-3330 NJ
Companies in which Cameron Durrant is an Insider
ANAVEX LIFE SCIENCES CORP.
Trading Symbol: AVXLIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Cameron Durrant: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2009
$AVXL Market Capitalization: $213.50M
$AVXL Previous Close: $5.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HUMANIGEN, INC
Trading Symbol: KBIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cameron Durrant: Chief Executive Officer, Chairman and CEO
Holdings: 557,207 shares
Current Value: $1,610,328
Latest Transaction: Mar 15 2021
$KBIO Market Capitalization: $44.71M
$KBIO Previous Close: $2.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNE PHARMACEUTICALS INC
Trading Symbol: IMNPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cameron Durrant: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 27 2017
$IMNP Market Capitalization: $23.82M
$IMNP Previous Close: $0.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Cameron Durrant
Sentiment: All, AVXL, KBIO, IMNP
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 15 2021 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 16.07 | 652,640 | 10,487,925 | 652,640 | |
Oct 07 2020 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 12.14 | 82,622 | 1,003,031 | 82,622 | |
May 21 2020 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.86 | 250,000 | 215,000 | 250,000 | |
Jan 29 2020 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.40 | 318,103 | 127,241 | 318,103 | |
Jun 05 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 1.25 | 8,000 | 10,000 | 557,207 | 549.2 K to 557.2 K (+1.46 %) |
May 31 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Buy | J | 0.00 | 235,624 | 0 | 549,207 | 313.6 K to 549.2 K (+75.14 %) |
Apr 25 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | M | 0.67 | 75,000 | 49,875 | 8,359,771 |